Inexperience Makes CDMOs Struggle With Cell And Gene Therapy
CDMOs (contract development and manufacturing organizations) are facing challenges due to the increasing number of companies preparing to scale up their cell and gene...
$85bn M&A Splurge Helps In Big Pharma Dealmaking Recovery
It is well to be noted that pharma and biotech companies splurged a whopping $85 billion in the first five months of 2023, which...
FDA Releases Draft Guidance On Digital Health Technologies
The US Food and Drug Administration has released a draft guidance on good clinical practices (GCPs) to improve the design and implementation of clinical...
Researchers Utilize AI To Combat Drug-Resistant Bacterium
McMaster University and Massachusetts Institute of Technology scientists leverage artificial intelligence to uncover a novel antibiotic named abaucin. This breakthrough has the potential to...
Targeting Tumor-Positive Lymph Nodes Boosts Cancer Treatment
Scientists at Tohoku University in Japan have made a significant discovery in the field of cancer treatment. They have found a new approach to...
AMR Certification For Responsible Antibiotic Manufacturing
BSI, a UK standards body, introduced a new certification called the Minimized Risk of Antimicrobial Resistance (AMR) to promote responsible antibiotic manufacturing in the...
Ovarian Cancer Type Gets An Effective Targeted Drug Combo
A targeted drug combination for patients suffering from an ovarian cancer type can be nearly twice as effective as the next-best treatment, according to...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...




















